Julio Chavez, MD, MD, discussed treatment options for LBCL after relapsing on CAR T-cell therapy.
Targeted Oncology Staff
Advertisement
Articles by Targeted Oncology Staff
Experts discussed challenges with treating relapsed or refractory diffuse large B-cell lymphoma.
Experts discussed treatment for patients with transplant-ineligible diffuse large B-cell lymphoma.
Early safety and efficacy data support the use of natural killer T (NKT) cells in patients with stage IV relapsed/refractory neuroblastoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
